Small cell carcinoma of the ovary, hypercalcemic type : model development and preclinical drug testing
Explore this paper's citation graph
- Type
- article
- Published
- 2018-01-01
- Cited by
- 0
- References
- 133
- Access
- Open access
- OpenAlex
- https://openalex.org/W2938828584
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:145979439
Keywords
Ovary, Medicine, Drug development, Drug, Internal medicine
References
- SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis
- Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group).
- Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging.
- A patient-like orthotopic implantation nude mouse model of highly metastatic human ovarian cancer
- WHO classification of tumours of female reproductive organs
- Orthotopic Metastatic Mouse Models for Anticancer Drug Discovery and Evaluation: a Bridge to the Clinic
- Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
- Enhancing the efficacy of cisplatin in ovarian cancer treatment – could arsenic have a role
- Purification and biochemical heterogeneity of the mammalian SWI‐SNF complex.
- Acquisition of a single EZH2 D1 domain mutation confers acquired resistance to EZH2-targeted inhibitors
- No small surprise – small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour
- Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
- Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes
- Differential cyclic AMP responses to calcitonin among human ovarian carcinoma cell lines: A calcitonin‐responsive line derived from a rare tumor type
- Human parathyroid hormone‐related protein in ovarian small cell carcinoma. An immunohistochemical study
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
- Five SWI genes are required for expression of the HO gene in yeast.
- The genetic basis of emotional behaviour in mice
- Clinical characteristics of clear cell carcinoma of the ovary.
- In vivo horizontal oncogenesis by a human tumor in nude mice.
Cited by
No citing papers recorded for this paper.
Related papers
- Establishing a Human Renal Cell Carcinoma Tumorgraft Platform for Preclinical Drug Testing
- Establishment of various biliary tract carcinoma cell lines and xenograft models for appropriate preclinical studies
- GSK-3 IS A POTENTIAL THERAPEUTIC TARGET FOR THE TREATMENT OF RENAL CELL CARCINOMA (RCC): PRECLINICAL IN VITRO AND IN VIVO INVESTIGATION
- Differential sensitivity of pancreatic adenocarcinoma cell lines to chemotherapeutic agents in culture.
- Patient-derived xenografts: a promising resource for preclinical cancer research
- Chemosensitivity testing: another chapter.
- Mouse models in squamous cell lung cancer: impact for drug discovery